|
FOXJ2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.699900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.123100E-03 |
| Normal-vs-Stage2 |
8.646500E-02 |
| Normal-vs-Stage3 |
3.437400E-01 |
| Normal-vs-Stage4 |
3.067800E-01 |
| Stage1-vs-Stage2 |
8.478400E-01 |
| Stage1-vs-Stage3 |
4.015800E-01 |
| Stage1-vs-Stage4 |
8.525200E-01 |
| Stage2-vs-Stage3 |
6.026000E-01 |
| Stage2-vs-Stage4 |
8.045400E-01 |
| Stage3-vs-Stage4 |
5.271000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.218170E-02 |
| Normal-vs-AfricanAmerican |
4.931800E-01 |
| Normal-vs-Asian |
9.915300E-03 |
| Caucasian-vs-AfricanAmerican |
1.443150E-01 |
| Caucasian-vs-Asian |
3.182000E-01 |
| AfricanAmerican-vs-Asian |
1.274200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.838400E-03 |
| Normal-vs-Female |
9.751200E-01 |
| Male-vs-Female |
2.271600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.516200E-02 |
| Normal-vs-Extreme_Weight |
1.995090E-03 |
| Normal-vs-Obese |
8.457000E-01 |
| Normal-vs-Extreme_Obese |
5.972300E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.413600E-01 |
| Normal_Weight-vs-Obese |
4.102100E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.702200E-01 |
| Extreme_Weight-vs-Obese |
8.918900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.187000E-01 |
| Obese-vs-Extreme_Obese |
2.623800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.598200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.371800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.102090E-03 |
| Normal-vs-Age(81-100Yrs) |
4.810400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.245400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.513580E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.020200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.740800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.634200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.149990E-01 |
| Normal-VS-Type2 PRCC |
1.56662999999391E-05 |
| Normal-VS-KIRP CIMP |
6.354200E-01 |
| Normal-VS-Unclassified PRCC |
7.325600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.791500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.269600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.005400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.339300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.799870E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.345800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.040600E-03 |
| Normal-vs-N1 |
8.035200E-01 |
| Normal-vs-N2 |
6.468400E-01 |
| N0-vs-N1 |
1.232170E-01 |
| N0-vs-N2 |
1.252230E-01 |
| N1-vs-N2 |
7.353600E-01 |
|
|
